Thoracoscopic Transthoracic Hepatectomy for Hepatocellular Carcinoma in Budd‐Chiari Syndrome

TL;DR

A minimally invasive surgery called thoracoscopic transthoracic hepatectomy was successfully used to treat liver cancer in a patient with Budd-Chiari syndrome.

Contribution

The paper introduces thoracoscopic transthoracic hepatectomy as a feasible surgical option for hepatocellular carcinoma in high-risk patients with Budd-Chiari syndrome.

Findings

Thoracoscopic transthoracic hepatectomy was successfully performed in an 88-year-old patient with Budd-Chiari syndrome and hepatocellular carcinoma.

Preoperative hemodynamic evaluation using angiography enabled safe surgical planning.

The procedure is suggested as a feasible and effective option for HCC in high-risk patients.

Abstract

Budd‐Chiari syndrome (BCS), caused by venous outflow obstruction, results in hepatic congestion and portal hypertension. BCS is also associated with a relatively high incidence of hepatocellular carcinoma (HCC). Selecting a minimally invasive approach based on hemodynamic assessment for the management of HCC arising from BCS is essential. A hepatic tumor located in liver segment 8 region was identified in an 88‐year‐old female patient with BCS. Following a detailed preoperative hemodynamic evaluation using angiography, a thoracoscopic transthoracic hepatectomy (TTH) was successfully performed. TTH may represent a feasible and effective surgical option for HCC in high‐risk patients, including those with BCS.

Figures